News related to Nexavar (Sorafenib) and/or conditions it is approved for
Gene expression profile may identify patients with renal cell carcinoma unlikely to benefit from nivolumab
Source: Urology / Nephrology News From Medical News Today [2016.08.08]
Renal cell carcinomas positive for the protein PD-L1 from patients who did not respond to treatment with the anti-PD-1 therapeutic nivolumab (Opdivo) had significantly higher expression of genes...
Renal Cell Carcinoma
Source: MedicineNet Kidney Cancer Specialty [2016.06.29]
Title: Renal Cell Carcinoma
Category: Doctor's & Expert's views on Symptoms
Created: 6/29/2016 12:00:00 AM
Last Editorial Review: 6/29/2016 12:00:00 AM
Rethinking Cytoreductive Nephrectomy in Metastatic RCC
Source: Medscape General Surgery Headlines [2016.08.24]
Recent data suggest that cytoreductive nephrectomy may confer a significant survival advantage in metastatic renal cell carcinoma.